Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays. OH&RM [Internet]. 2023 Dec. 13 [cited 2026 Sep. 16];:77. Available from: https://www.journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/657